drugset
drugset / Trial / NCT06117046

The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Single-blind, Randomized Controlled Pilot Study

NCT06117046 ↗

Phase 4 Completed 234 enrolled Nanfang Hospital, Southern Medical University
RandomizedParallel-groupOpen-labelPrevention

Summary

The study was a single-center, randomized controlled pilot study. To explore the cardioprotective effect of cardiopeptidin on non-heart disease patients with severe cardiac injury by comparing whether cardiopeptidin was used.

Timeline

Start
2023-02-27
Primary completion
2023-11-25
Completion
2023-11-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Cardiopeptidin Unknown 60 mg Intravenous

Indications

No indication recorded.